ATE319421T1 - Lokale arzneistoffabgabe - Google Patents

Lokale arzneistoffabgabe

Info

Publication number
ATE319421T1
ATE319421T1 AT00931465T AT00931465T ATE319421T1 AT E319421 T1 ATE319421 T1 AT E319421T1 AT 00931465 T AT00931465 T AT 00931465T AT 00931465 T AT00931465 T AT 00931465T AT E319421 T1 ATE319421 T1 AT E319421T1
Authority
AT
Austria
Prior art keywords
polymer
monomers
coating
implant
stent
Prior art date
Application number
AT00931465T
Other languages
English (en)
Inventor
Lee Serendib Rowan
Peter William Stratford
Alistair Stewart Taylor
Terrence Albert Vick
Original Assignee
Biocompatibles Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibles Uk Ltd filed Critical Biocompatibles Uk Ltd
Application granted granted Critical
Publication of ATE319421T1 publication Critical patent/ATE319421T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00931465T 1999-05-27 2000-05-30 Lokale arzneistoffabgabe ATE319421T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99304140 1999-05-27
EP99304584 1999-06-11

Publications (1)

Publication Number Publication Date
ATE319421T1 true ATE319421T1 (de) 2006-03-15

Family

ID=26153486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00931465T ATE319421T1 (de) 1999-05-27 2000-05-30 Lokale arzneistoffabgabe

Country Status (7)

Country Link
US (2) US6872225B1 (de)
EP (1) EP1180013B1 (de)
JP (1) JP5140220B2 (de)
AT (1) ATE319421T1 (de)
AU (1) AU4941400A (de)
DE (1) DE60026513T2 (de)
WO (1) WO2001001957A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445792B2 (en) * 2003-03-10 2008-11-04 Abbott Laboratories Medical device having a hydration inhibitor
US20030129215A1 (en) * 1998-09-24 2003-07-10 T-Ram, Inc. Medical devices containing rapamycin analogs
US6890546B2 (en) 1998-09-24 2005-05-10 Abbott Laboratories Medical devices containing rapamycin analogs
US20030040790A1 (en) * 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US20020099438A1 (en) * 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
JP5140220B2 (ja) * 1999-05-27 2013-02-06 バイオコンパテイブルズ・ユーケイ・リミテツド 局所的な薬剤送達
US20070032853A1 (en) * 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6746686B2 (en) 2000-01-24 2004-06-08 Biocompatibles Uk Limited Coated implants
US8236048B2 (en) 2000-05-12 2012-08-07 Cordis Corporation Drug/drug delivery systems for the prevention and treatment of vascular disease
US20050002986A1 (en) * 2000-05-12 2005-01-06 Robert Falotico Drug/drug delivery systems for the prevention and treatment of vascular disease
CA2424029C (en) 2000-09-29 2008-01-29 Cordis Corporation Coated medical devices
US20060222756A1 (en) * 2000-09-29 2006-10-05 Cordis Corporation Medical devices, drug coatings and methods of maintaining the drug coatings thereon
US7261735B2 (en) * 2001-05-07 2007-08-28 Cordis Corporation Local drug delivery devices and methods for maintaining the drug coatings thereon
US7018405B2 (en) 2000-12-22 2006-03-28 Avantec Vascular Corporation Intravascular delivery of methylprednisolone
US6939375B2 (en) 2000-12-22 2005-09-06 Avantac Vascular Corporation Apparatus and methods for controlled substance delivery from implanted prostheses
US7083642B2 (en) 2000-12-22 2006-08-01 Avantec Vascular Corporation Delivery of therapeutic capable agents
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6471980B2 (en) 2000-12-22 2002-10-29 Avantec Vascular Corporation Intravascular delivery of mycophenolic acid
GB0100761D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
GB0100760D0 (en) 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
NZ528994A (en) * 2001-04-26 2006-02-24 Control Delivery Sys Inc Sustained release drug delivery system containing codrugs
US8182527B2 (en) * 2001-05-07 2012-05-22 Cordis Corporation Heparin barrier coating for controlled drug release
US20030044514A1 (en) * 2001-06-13 2003-03-06 Richard Robert E. Using supercritical fluids to infuse therapeutic on a medical device
US7056338B2 (en) 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
PT1478648E (pt) 2002-02-01 2014-07-15 Ariad Pharma Inc Compostos contendo fósforo e suas utilizações
US20030208166A1 (en) * 2002-05-06 2003-11-06 Schwartz Anthony H. Implantable device with free-flowing exit and uses thereof
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
DE10237572A1 (de) * 2002-08-13 2004-02-26 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Stent mit polymerer Beschichtung
US20050038504A1 (en) * 2003-01-22 2005-02-17 Harry Halleriet Kit for applying drug coating to a medical device in surgeon room
US7371229B2 (en) 2003-01-28 2008-05-13 Felix Theeuwes Dual electrode advanced electrochemical delivery system
EP1590388A2 (de) * 2003-02-05 2005-11-02 Biocompatibles UK Limited Blockcopolymere
US8715771B2 (en) * 2003-02-26 2014-05-06 Abbott Cardiovascular Systems Inc. Coated stent and method of making the same
US7255891B1 (en) 2003-02-26 2007-08-14 Advanced Cardiovascular Systems, Inc. Method for coating implantable medical devices
EP1610823B1 (de) 2003-03-28 2011-09-28 Innovational Holdings, LLC Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
US7226473B2 (en) 2003-05-23 2007-06-05 Brar Balbir S Treatment of stenotic regions
CA2558141C (en) * 2004-02-28 2012-03-06 Hemoteq Gmbh Biocompatible coating, method and use of medical surfaces
JP3953092B2 (ja) * 2004-04-27 2007-08-01 コニカミノルタオプト株式会社 対物レンズ及び光ピックアップ装置
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20060051393A1 (en) * 2004-09-08 2006-03-09 Medtronic, Inc. Method of manufacturing drug-eluting medical device
WO2006031532A2 (en) * 2004-09-10 2006-03-23 Surmodics, Inc. Methods, devices, and coatings for controlled active agent release
FI20041515A7 (fi) * 2004-11-25 2006-05-26 Oy Lasermark Ab Menetelmä lääketieteellisten stenttien valmistamiseksi
WO2006063430A1 (en) * 2004-12-16 2006-06-22 Miv Therapeutics Inc. Multi-layer drug delivery device and method of manufacturing same
AU2006221046B2 (en) 2005-03-03 2012-02-02 Icon Medical Corp. Improved metal alloys for medical device
US7540995B2 (en) * 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US10076641B2 (en) 2005-05-11 2018-09-18 The Spectranetics Corporation Methods and systems for delivering substances into luminal walls
US20060275341A1 (en) * 2005-06-02 2006-12-07 Miv Therapeutics Inc. Thin foam coating comprising discrete, closed-cell capsules
US20070032865A1 (en) * 2005-08-05 2007-02-08 Otis David R Prosthesis having a coating and systems and methods of making the same
US20070038273A1 (en) * 2005-08-10 2007-02-15 Maurice Bales Method and apparatus for improved photon irradiation therapy and treatment of pain
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US20070224244A1 (en) * 2006-03-22 2007-09-27 Jan Weber Corrosion resistant coatings for biodegradable metallic implants
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
WO2008006912A2 (en) 2006-07-14 2008-01-17 Biocompatibles Uk Limited Polymer
WO2008006911A1 (en) * 2006-07-14 2008-01-17 Biocompatibles Uk Limited Coated implant
US20080051911A1 (en) * 2006-08-23 2008-02-28 Wilson-Cook Medical Inc. Stent with antimicrobial drainage lumen surface
CA2663250A1 (en) 2006-09-15 2008-03-20 Boston Scientific Limited Bioerodible endoprostheses and methods of making the same
US7780730B2 (en) 2006-09-25 2010-08-24 Iyad Saidi Nasal implant introduced through a non-surgical injection technique
JP2010517703A (ja) 2007-02-09 2010-05-27 タヘリ ラドュカ エルエルシー 血管移植片およびそれを加工する方法
US8084077B2 (en) 2007-05-25 2011-12-27 Abbott Laboratories One-step phosphorylcholine-linked polymer coating and drug loading of stent
US8425591B1 (en) * 2007-06-11 2013-04-23 Abbott Cardiovascular Systems Inc. Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US7567129B2 (en) * 2007-06-29 2009-07-28 Intel Corporation Monolithic flexible power amplifier using integrated tunable matching networks
AU2008293471B2 (en) 2007-08-31 2013-10-24 Cook Medical Technologies Llc Medical implant having improved drug eluting features
US20110129514A1 (en) * 2007-09-06 2011-06-02 Hossainy Syed F A Hygroscopic coating on a balloon device
US20110137243A1 (en) * 2007-09-06 2011-06-09 Abbott Cardiovascular Systems Inc. Coating On A Balloon Device
US8221821B1 (en) * 2007-11-09 2012-07-17 Abbott Cardiovascular Systems Inc. Methods of modifying ablumenal/lumenal stent coating thicknesses
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
TWI385926B (zh) * 2008-05-15 2013-02-11 Realtek Semiconductor Corp 時脈產生器
US8187623B2 (en) 2008-06-25 2012-05-29 Boston Scientific Scimed, Inc. Medical copolymers
US20110251281A1 (en) * 2008-09-08 2011-10-13 National Institute For Materials Science Composite Material Comprising High-Molecular-Weight Matrix and Low-Molecular-Weight Organic Compound and Process For Producing Same
DE102008043724A1 (de) 2008-11-13 2010-05-20 Biotronik Vi Patent Ag Erhöhung der Effizienz pharmazeutische Wirkstoffe-freisetzender Medizinprodukte durch Kombination mit einem Inhibitor des Transportproteins P-Glycoprotein
WO2010059586A1 (en) 2008-11-19 2010-05-27 Entrigue Surgical, Inc. Apparatus and methods for correcting nasal valve collapse
US8802121B2 (en) * 2009-06-02 2014-08-12 Surmodics, Inc. Silane-functionalized hydrophobic α(1→4)glucopyranose polymers and polymeric matrices for implantation or injection
EP2482863A1 (de) * 2009-09-30 2012-08-08 SurModics, Inc. Hydrophobe polysaccharide mit silyletherverbindungen mit verstärktem abbau und daraus hergestellte medizinprodukte
US9414901B2 (en) * 2009-10-01 2016-08-16 Indiana University Research And Technology Corporation Drug-eluting stents for adenosine receptor modulation
US8568760B2 (en) * 2009-12-30 2013-10-29 Surmodics, Inc. Hydrophobic polysaccharides with pendent groups having terminal reactive functionalities and medical uses thereof
WO2011082296A1 (en) * 2009-12-31 2011-07-07 Surmodics, Inc. Silyl ether-modified hydrophilic polymers and uses for medical articles
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
WO2011119573A1 (en) 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
US8940799B2 (en) * 2010-03-25 2015-01-27 Medtronic Xomed, Inc. Adjusting drug loading in polymeric materials
EP2380604A1 (de) 2010-04-19 2011-10-26 InnoRa Gmbh Verbesserte Beschichtungsformulierung zum Einritzen oder Schneiden von Ballonkathetern
WO2011150001A2 (en) 2010-05-25 2011-12-01 3M Innovative Properties Company Antimicrobial coatings
US9295663B2 (en) 2010-07-14 2016-03-29 Abbott Cardiovascular Systems Inc. Drug coated balloon with in-situ formed drug containing microspheres
KR101723272B1 (ko) 2011-06-21 2017-04-18 비브이더블유 홀딩 에이쥐 보스웰릭산을 포함하는 메디컬 디바이스
US9006305B2 (en) 2011-09-01 2015-04-14 Vertellus Specialties Inc. Biocompatible material
SG11201400287XA (en) * 2011-09-01 2014-03-28 Vertellus Specialties Inc Methods for producing biocompatible materials
GB201119363D0 (en) * 2011-11-10 2011-12-21 Vertellus Specialities Inc Polymerisable material
DK2961350T3 (en) 2013-02-27 2018-05-28 Spirox Inc Nose implants and systems
US11850331B2 (en) * 2013-03-11 2023-12-26 Teleflex Medical Incorporated Devices with anti-thrombogenic and anti-microbial treatment
US10597540B2 (en) * 2013-05-27 2020-03-24 Jsr Corporation Surface treatment agent for surface configured from inorganic material, tool and device having modified surface, and method for manufacturing tool and device
BR112016030273A2 (pt) 2014-06-24 2017-08-22 Icon Medical Corp Dispositivo médico e método para formar o referido dispositivo
EP3185819B1 (de) 2014-08-26 2025-02-19 Stryker Corporation Nasenimplantat
DE202015002048U1 (de) 2015-03-16 2015-09-24 Han Bock-Sun Implantat
CN113349985A (zh) 2015-09-25 2021-09-07 斯贝洛克斯公司 鼻植入物和系统及使用方法
WO2017151548A1 (en) 2016-03-04 2017-09-08 Mirus Llc Stent device for spinal fusion
ITUA20162094A1 (it) 2016-03-29 2017-09-29 Cid S P A Perfezionamenti negli stent per il rilascio di principi attivi
CN109068955B (zh) 2016-05-02 2022-10-28 茵泰勒斯医疗公司 鼻瓣植入物及其植入方法
WO2018017879A1 (en) 2016-07-22 2018-01-25 University Of Washington Zwitterionic microgels, their assemblies and related formulations, and methods for their use
CN108524471B (zh) * 2018-04-18 2019-03-01 中山万汉制药有限公司 奥利司他纳米微球及其在制备治疗肥胖症药物中的用途
EP3860669B1 (de) * 2018-10-01 2024-04-03 MicroVention, Inc. Medizinische vorrichtungen
WO2022061163A1 (en) * 2020-09-17 2022-03-24 The University Of North Carolina At Chapel Hill Methods, systems and devices for post-fabrication drug loading

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674192A (en) 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5843089A (en) 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
DE69131486T2 (de) * 1990-12-28 2000-02-17 Boston Scientific Corp., Natick Katheter als arzneiabgabesystem
US5739236A (en) 1991-04-24 1998-04-14 Biocompatibles Limited Biocompatible zwitterion polymers
US5705583A (en) 1991-07-05 1998-01-06 Biocompatibles Limited Polymeric surface coatings
US6090901A (en) 1991-07-05 2000-07-18 Biocompatibles Limited Polymeric surface coatings
WO1993001221A1 (en) 1991-07-05 1993-01-21 Biocompatibles Limited Polymeric surface coatings
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
CA2094858C (en) * 1992-04-28 2004-06-15 Robert D. Mitchell Method of treating hyperproliferative vascular disease
GB9301701D0 (en) * 1993-01-28 1993-03-17 Biocompatibles Ltd New zwitterionic materials
WO1994021308A1 (en) 1993-03-18 1994-09-29 Cedars-Sinai Medical Center Drug incorporating and releasing polymeric coating for bioprosthesis
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5380299A (en) 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
WO1995010989A1 (en) 1993-10-19 1995-04-27 Scimed Life Systems, Inc. Intravascular stent pump
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
GB9624130D0 (en) * 1996-11-20 1997-01-08 Biocompatibles Ltd Biocompatible compositions
WO1998030615A1 (en) * 1997-01-10 1998-07-16 Biocompatibles Limited Polymers
US5879697A (en) * 1997-04-30 1999-03-09 Schneider Usa Inc Drug-releasing coatings for medical devices
WO1998057671A2 (en) * 1997-06-18 1998-12-23 Boston Scientific Corporation Polycarbonate-polyurethane dispersions for thrombo-resistant coatings
US5897911A (en) 1997-08-11 1999-04-27 Advanced Cardiovascular Systems, Inc. Polymer-coated stent structure
WO1999008729A1 (en) * 1997-08-13 1999-02-25 Boston Scientific Limited Loading and release of water-insoluble drugs
DE19744135C1 (de) 1997-09-29 1999-03-25 Schering Ag Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
CA2337534C (en) * 1998-07-21 2008-05-06 Biocompatibles Limited Coating
JP5140220B2 (ja) * 1999-05-27 2013-02-06 バイオコンパテイブルズ・ユーケイ・リミテツド 局所的な薬剤送達
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6251136B1 (en) * 1999-12-08 2001-06-26 Advanced Cardiovascular Systems, Inc. Method of layering a three-coated stent using pharmacological and polymeric agents
US6746686B2 (en) * 2000-01-24 2004-06-08 Biocompatibles Uk Limited Coated implants

Also Published As

Publication number Publication date
US20040208985A1 (en) 2004-10-21
WO2001001957A1 (en) 2001-01-11
EP1180013A1 (de) 2002-02-20
DE60026513D1 (de) 2006-05-04
JP2003503157A (ja) 2003-01-28
US7754272B2 (en) 2010-07-13
EP1180013B1 (de) 2006-03-08
JP5140220B2 (ja) 2013-02-06
AU4941400A (en) 2001-01-22
DE60026513T2 (de) 2006-10-05
US6872225B1 (en) 2005-03-29

Similar Documents

Publication Publication Date Title
ATE319421T1 (de) Lokale arzneistoffabgabe
US6143353A (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
CA2506997A1 (en) Controlled drug delivery using polymer macromolecules to retard drug elution
AU6042796A (en) Controlled release formulation having a preformed passageway
CA2193129A1 (en) Transdermal drug delivery system
CA2398035A1 (en) Timed pulsatile drug delivery systems
US20060280795A1 (en) Specific time-delayed burst profile delivery system
AU570712B2 (en) Crosslinked, porous polymers for controlled drug delivery
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
EP0250374B1 (de) Therapeutisches System mit geregelter Wirkstoffabgabe
DK1477187T3 (da) Formulering til kontrolleret frigivelse af medikamenter ved at kombinere hydrofile og hydrofobe stoffer
CA2098984A1 (en) Drug delivery system
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
WO2001043749A3 (en) Pharmaceutical implant containing immediate-release and sustained-release components and method of administration
CA2105079A1 (en) Composition and method for delivery of drugs
FI906344A0 (fi) Kontrollerat frigoerande farmaceutiskt preparat.
BR0114633A (pt) Formulações farmacêuticas com liberação retardada
CA2355313A1 (en) Controlled-release biocompatible ocular drug delivery implant devices and methods
IL135502A (en) A system that completely suspends the release of a drug in the gastrointestinal tract
AU6136199A (en) Dosage form comprising therapeutic formulation
KR950005301A (ko) 방출 개시 제어 및 방출 속도 제어형 제제
WO1998029095A3 (en) Sustained release cisapride mini-tablet formulation
WO2005102222A3 (en) Bioresorbable stent with beneficial agent reservoirs
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties